Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Abiraterone +/- cabazitaxel in defining complete...
Conference

Abiraterone +/- cabazitaxel in defining complete response in prostatectomy (ACDC-RP) trial.

Abstract

TPS5095

Authors

Joshua AM; Fleshner NE; Chin J; Emmenegger U; Gleave ME; Hotte SJ; Sweet J; Collins C; Boutros PC; Lupien M

Volume

35

Pagination

pp. tps5095-tps5095

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2017

DOI

10.1200/jco.2017.35.15_suppl.tps5095

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X